Hosted on MSN13m
A-Mark Precious Metals (AMRK) Q2 Earnings Miss Estimates
A-Mark Precious Metals (AMRK) came out with quarterly earnings of $0.55 per share, missing the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.90 per share a year ago.
Fortune Brands Innovations: Q4 Earnings Snapshot
Fortune Brands Innovations expects full-year earnings in the range of $4.15 to $4.45 per share. This story was generated by Automated Insights ( http://automatedinsights.com/ap) using data from Zacks ...
What is Zacks Small Cap’s Forecast for PLX FY2025 Earnings?
Equities research analysts at Zacks Small Cap cut their FY2025 earnings per share estimates for shares of Protalix BioTherapeutics in a report released on Monday, February 3rd. Zacks Small Cap analyst ...
Hosted on MSN13m
Genpact (G) Tops Q4 Earnings and Revenue Estimates
Genpact (G) came out with quarterly earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.82 per share a year ago. These figures are ...
The Zacks Analyst Blog Highlights Meta, Mastercard, Adobe, Investors Title Company and MIND
Today's Research Daily features the Q4 earnings season scorecard and updated analyst reports on 16 major stocks, including Meta Platforms, Mastercard and Adobe, as well as two micro-cap stocks ...
CNO: Q4 Earnings Snapshot
The Carmel, Indiana-based company said it had net income of $1.58 per share. Earnings, adjusted for non-recurring gains, came to $1.31 per share. The results topped Wall Street expectations. The ...
Morningstar1mon
Zacks All-Cap Core Institutional
Zacks All-Cap Core Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ten ...
Yahoo Finance10d
Zacks Market Edge Highlights: Red Cat, Barrick Gold, Arista Networks, Nio and Apple
Chicago, IL – January 27, 2025 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec.
Zacks.com on MSN8h
Zacks Initiates Coverage of bioAffinity With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of bioAffinity Technologies, Inc. BIAF, assigning a "Neutral" recommendation to the company's shares. This assessment comes amid a mixed ...
Morningstar1mon
Zacks Dividend Institutional ZDIIX
Zacks Dividend Fund earns an Average Process Pillar rating. The predominant contributor to the rating is the firm's retention rate of the firm's portfolio managers, which is 100% over the ...